Alitretinoin in the Treatment of Chronic Hand Eczema
The purpose of the study is to investigate the safety and efficacy of alitretinoin in chronic hand eczema that is refractory to topical corticosteroids.
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Open Label Treatment of Patients With Chronic Hand Dermatitis Who Have Participated in a Previous Clinical Trial Involving Oral Alitretinoin|
- Safety assessments
- Efficacy (Physicians Global Assessment)
|Study Start Date:||May 2007|
Chronic hand eczema is a frequent and distressing disease. The course of the disease is of chronic-relapsing nature. In a phase III study alitretinoin was clinically effective for patients with severe chronic hand eczema refractory to topical treatment. This study investigates the safety and efficacy of alitretinoin who previously have participated in a clinical trial involving alitretinoin.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00519675
|Saint Etienne, France|
|Study Director:||Jürgen Maares, MD||Basilea Pharmaceutica|